Skip to content
Search

Latest Stories

Pharmacists witness impact of prescription charges on people in England, RPS survey reveals

The result from the Royal Pharmaceutical Society (RPS)’s survey showed that pharmacists witnessed ‘the cost of living is having an impact on whether people can afford prescription medicines in England’.

RPS has long campaigned to remove prescription charges for people with long-term conditions in England because they create a financial barrier to patients receiving the medicines needed to keep them well.


The charge currently stands at £9.35 per item prescrib9ed and an annual rise usually occurs in April. Prescriptions are free for people in Scotland, Wales and Northern Ireland.

One in two pharmacists who responded to the survey said they’ve seen an increase in the last six months in patients asking them which medicines on their prescription they can 'do without' due to affordability issues.

One in two pharmacists had seen a rise in people not collecting their prescription, whilst two out of three pharmacists reported an increase in being asked if there was a cheaper, over-the-counter substitute for the medicine they had been prescribed.

Chair of the RPS in England Ms Thorrun Govind said: “We are deeply concerned that people are having to make choices about their health based on their ability to pay. No one should have to make choices about rationing their medicines and no one should be faced with a financial barrier to getting the medicines they need.

“Prescription charges are an unfair tax on health which disadvantages working people on lower incomes who are already struggling with food and energy bills.

“Reducing access to medicines leads to poorer health, time off work and can result in admissions to hospital, the cost of which must be set against any income gained from prescription charges.

“Prescriptions have been free for people in Scotland, Wales and Northern Ireland for many years. We urgently need an overhaul of the system in England to ensure it supports access to medicines for people with long-term conditions at the sharp end of the cost of living crisis.

“Ultimately we want to see the prescription charge abolished for people with long-term conditions so medicines are free to access in England, just like they are in the rest of the UK.”

Tips from RPS for saving money on medicines include:

  • Depending on how many medicines you need it may be cheaper to buy a prescription ‘season ticket’ known as a prescription prepayment certificate available from the NHS. You will save money if you need more than 3 items in 3 months, or 11 items in 12 months.
  • Ask your pharmacist if there is an equivalent medicine costing less than the charge which you can buy over the counter
  • Ask your pharmacist or GP to review your medicines to ensure they are appropriate and that you get the best out of them.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less